WITHUS PHARMACEUTICAL CO.,LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8,140 KRW | +0.49% |
|
+1.75% | -16.34% |
| Sales 2022 | 64.68B 47.02M 3.76B | Sales 2023 | 80.12B 58.25M 4.66B | Capitalization | 128B 93.32M 7.47B |
|---|---|---|---|---|---|
| Net income 2022 | 2.48B 1.8M 144M | Net income 2023 | 7.96B 5.79M 463M | EV / Sales 2022 | 1.83 x |
| Net cash position 2022 | 5.09B 3.7M 296M | Net Debt 2023 | 8.81B 6.4M 513M | EV / Sales 2023 | 1.71 x |
| P/E ratio 2022 |
49.8
x | P/E ratio 2023 |
16.1
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 45.84% |
More Fundamentals
* Assessed data
| 1 day | +0.49% | ||
| 1 week | +1.75% | ||
| Current month | -6.86% | ||
| 1 month | -6.86% | ||
| 3 months | -1.69% | ||
| 6 months | -4.24% | ||
| Current year | -16.34% |
1 week
7 960.00
8 190.00
1 month
7 530.009 120.00
Current year
7 530.0010 230.00
1 year
6 210.0013 680.00
3 years
5 960.0017 200.00
5 years
5 960.0027 233.33
10 years
5 960.0027 233.33
| Managers | Title | Age | Since |
|---|---|---|---|
Dae-Young Sung
CEO | Chief Executive Officer | 65 | - |
Kwang-Young Kwon
BRD | Director/Board Member | 63 | - |
Sung-Chul Lee
AUD | Comptroller/Controller/Auditor | 66 | 30/11/18 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Dae-Young Sung
CEO | Chief Executive Officer | 65 | - |
Kwang-Young Kwon
BRD | Director/Board Member | 63 | - |
Yong-Ju Lee
BRD | Director/Board Member | 59 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/04/24 | 8,140 | +0.49% | 20,678 |
| 29/04/24 | 8,100 | +1.38% | 19,597 |
| 26/04/24 | 7,990 | -0.37% | 23,549 |
| 25/04/24 | 8,020 | -1.11% | 18,526 |
| 24/04/24 | 8,110 | +1.25% | 31,366 |
End-of-day quote Korea S.E., April 29, 2024
More quotes
Withus Pharmaceutical Co Ltd is Korea-based company mainly engaged in the production and sale of pharmaceuticals. The Company's main products include circulatory agents, musculoskeletal agents, digestive agents, antibiotics and other prescription drugs. And the Company is engaged in contract manufacturing operation(CMO).
Sector
Pharmaceuticals
Calendar
09/05/2024
- Q1 2024 Earnings Release (Projected)
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -16.34% | 77.66M | |
| +33.25% | 699B | |
| +26.20% | 571B | |
| -3.55% | 364B | |
| +18.16% | 326B | |
| +4.36% | 286B | |
| +14.98% | 236B | |
| +4.75% | 198B | |
| -10.22% | 194B | |
| -3.69% | 149B |
- Stock Market
- Equities
- A330350 Stock
